Ask.com
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Aptinyx Inc
(NQ:
APTX
)
4.000
USD
-0.020 (-0.50%)
Official Closing Price
Updated: 6:36 PM EST, Jan 22, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Aptinyx Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Aptinyx Announces Publication of Review Article Highlighting Preclinical Data in Medicine in Drug Discovery Demonstrating the Potential of NYX-2925 to Treat Chronic, Centralized Pain Conditions
January 19, 2021
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced the publication of a...
From
Business Wire News Releases
Aptinyx to Participate in H.C. Wainwright BioConnect 2021 Conference
January 05, 2021
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that company...
From
Business Wire News Releases
Aptinyx Announces Recommencement of Phase 2 Study of NYX-2925 in Patients With Painful Diabetic Peripheral Neuropathy
January 04, 2021
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that in December it...
From
Business Wire News Releases
Aptinyx to Present at the 39th Annual J.P. Morgan Healthcare Conference
December 21, 2020
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that the company...
From
Business Wire News Releases
First Week of APTX August 2021 Options Trading
December 18, 2020
Investors in Aptinyx Inc (APTX) saw new options begin trading this week, for the August 2021 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the...
Tags
Stocks
From
Market News Video
Qualcomm’s new chipset for wireless earbuds promises improved noise cancellation, all-day battery life
December 16, 2020
There are now so many wireless earbuds, it’s hard to keep track, but one of the reasons why we’ve seen this explosion in new and existing manufacturers entering this business is the availability of...
Tags
Alexa
aptx
telecommunications
From
TechCrunch
Aptinyx Appoints Andy Kidd, M.D., President and Chief Operating Officer
December 16, 2020
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced the appointment of...
From
Business Wire News Releases
Aptinyx Reports Third Quarter 2020 Financial Results and Recent Highlights
November 12, 2020
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today reported financial results for...
From
Business Wire News Releases
The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal
November 12, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
Penny Stocks
Benzinga
FPRX
From
Benzinga
Earnings Scheduled For November 12, 2020
November 12, 2020
Companies Reporting Before The Bell • Redhill Biopharma (NASDAQ:RDHL) is projected to report quarterly loss at $0.16 ...
Tags
NICE
TSEM
CTEK
From
Benzinga
Aptinyx to Participate in Upcoming Virtual Investor Conferences
November 10, 2020
EVANSTON, Ill., November 10, 2020 – Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders,...
From
Business Wire News Releases
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
November 08, 2020
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ...
Tags
PRAX
Small Cap
Penny Stocks
From
Benzinga
Aptinyx to Report Third Quarter Financial Results on Thursday, November 12, 2020
October 29, 2020
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that the company...
From
Business Wire News Releases
54 Biggest Movers From Yesterday
October 29, 2020
Gainers MediaAlpha, Inc. (NYSE: MAX) shares jumped 67.7% to close at $31.86 on Wednesday. The company raised $175.75 million in ...
Tags
NVUS
REKR
APLT
From
Benzinga
4 Penny Stocks To Watch At The End Of October 2020
October 28, 2020
From
Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Piper Sandler Initiates Coverage On Aptinyx On PTSD Candidate
October 27, 2020
The market’s skepticism around Aptinyx Inc’s (NASDAQ: APTX) post-traumatic stress disorder (PTSD) candidate appears ...
Tags
Analyst Ratings
Benzinga
Initiation
From
Benzinga
Benzinga's Top Upgrades, Downgrades For October 27, 2020
October 27, 2020
Upgrades According to UBS, the prior rating for United Parcel Service Inc (NYSE: UPS) was changed from Neutral to Buy. In the ...
Tags
NCR
XHR
Intraday Update
From
Benzinga
12 Healthcare Stocks Moving In Tuesday's Pre-Market Session
October 27, 2020
Gainers Scholar Rock Holding (NASDAQ:SRRK) stock moved upwards by 16.25% to $15.95 during Tuesday's pre-market session. The ...
Tags
GNFT
Movers
GALT
From
Benzinga
40 Stocks Moving in Tuesday's Pre-Market Session
October 27, 2020
Gainers 1847 Goedeker Inc. (NASDAQ: GOED) rose 125.8% to $15.60 in pre-market trading. 1847 Goedeker reported the purchase of ...
Tags
PEI
SPI
XLNX
From
Benzinga
Aptinyx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option
October 26, 2020
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced the closing of its...
From
Business Wire News Releases
56 Biggest Movers From Yesterday
October 23, 2020
Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares climbed 122.2% to close at $2.60 on Thursday after gaining over ...
Tags
CHU
TC
PLIN
From
Benzinga
12 Healthcare Stocks Moving In Thursday's Intraday Session
October 22, 2020
Gainers Align Tech (NASDAQ:ALGN) shares increased by 33.56% to $448.52 during Thursday's regular session. Align Tech's ...
Tags
ITRM
Benzinga
Top Gainers
From
Benzinga
45 Stocks Moving In Thursday's Mid-Day Session
October 22, 2020
Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares jumped 436% to $6.28 after gaining over 6% on ...
Tags
LLIT
GPOR
UNFI
From
Benzinga
Mid-Morning Market Update: Markets Edge Lower; Coca-Cola Earnings Top Views
October 22, 2020
Following the market opening Thursday, the Dow traded down 0.09% to 28184.34 while the NASDAQ fell 0.60% to 11,416.01. The S&P also ...
Tags
Earnings
Eurozone
Commodities
From
Benzinga
12 Healthcare Stocks Moving In Thursday's Pre-Market Session
October 22, 2020
Gainers Bio-Path Holdings (NASDAQ:BPTH) stock rose 28.71% to $5.29 during Thursday's pre-market session. The company's ...
Tags
Markets
Healthcare Stocks Pre/Market Movers
LLIT
From
Benzinga
40 Stocks Moving in Thursday's Pre-Market Session
October 22, 2020
Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) rose 194.9% to $3.45 in pre-market trading after gaining over 6% on ...
Tags
WEI
CBAT
MKGI
From
Benzinga
Aptinyx Announces Pricing of Public Offering of Common Stock
October 21, 2020
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced the pricing of its...
From
Business Wire News Releases
12 Healthcare Stocks Moving In Wednesday's Pre-Market Session
October 21, 2020
Gainers Lianluo Smart (NASDAQ:LLIT) shares moved upwards by 13.99% to $0.58 during Wednesday's pre-market session. The market ...
Tags
Top Gainers
Pre/Market Outlook
Benzinga
From
Benzinga
The Daily Biotech Pulse: Prothena Progress In Parkinson's Disease Pipeline, Fast Track For Xeris, Biogen Earnings
October 21, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
ICPT
TTNP
HALO
From
Benzinga
60 Biggest Movers From Yesterday
October 21, 2020
Gainers Dragon Victory International Limited (NASDAQ: LYL) shares jumped 47.6% to close at $3.75 on Tuesday in sympathy with the ...
Tags
LOGI
APTX
JG
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.